Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by LSV Asset Management

LSV Asset Management lessened its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 6.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 108,400 shares of the company’s stock after selling 6,900 shares during the period. LSV Asset Management’s holdings in Phibro Animal Health were worth $1,255,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. SG Americas Securities LLC purchased a new stake in Phibro Animal Health in the 3rd quarter valued at about $126,000. Illinois Municipal Retirement Fund acquired a new stake in shares of Phibro Animal Health in the third quarter valued at about $162,000. Jump Financial LLC acquired a new position in Phibro Animal Health during the 3rd quarter worth approximately $198,000. Barclays PLC grew its position in Phibro Animal Health by 59.8% in the third quarter. Barclays PLC now owns 35,638 shares of the company’s stock valued at $456,000 after acquiring an additional 13,332 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its position in shares of Phibro Animal Health by 20.9% during the third quarter. New York State Common Retirement Fund now owns 69,944 shares of the company’s stock worth $893,000 after purchasing an additional 12,110 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

PAHC stock opened at $17.70 on Friday. The stock’s 50 day moving average is $13.57 and its two-hundred day moving average is $12.07. Phibro Animal Health Co. has a 52-week low of $9.40 and a 52-week high of $17.75. The company has a market capitalization of $716.90 million, a PE ratio of 49.17, a P/E/G ratio of 6.30 and a beta of 0.63. The company has a quick ratio of 1.60, a current ratio of 3.12 and a debt-to-equity ratio of 1.66.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $249.90 million during the quarter, compared to the consensus estimate of $242.91 million. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. Analysts predict that Phibro Animal Health Co. will post 1.12 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Thursday, June 6th will be paid a $0.12 dividend. The ex-dividend date is Thursday, June 6th. This represents a $0.48 dividend on an annualized basis and a yield of 2.71%. Phibro Animal Health’s dividend payout ratio (DPR) is 133.33%.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.